21
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Explaining the slow transition of child-appropriate dosage formulations from the global to national level in the context of Uganda: a qualitative study

, , , , , & show all
Article: 19 | Received 08 Jan 2015, Accepted 24 Jun 2015, Published online: 24 Nov 2023

References

  • World Health Assembly; Resolution WHA 60.20 2007 Better medicines for children,. http://apps.who.int/medicinedocs/en/d/Js21455ar/. Accessed 19 March 2015.
  • Finney E. Children’s medicines: a situation analysis November 2011. Retrieved from: Make medicines child size; http://apps.who.int/medicinedocs/en/d/Js20020en/. Date accessed 06/13/2015
  • Nsabagasani X, Ogwal-Okeng J, Mbonye A, Ssengooba F, Nantanda R, Muyinda H, et al. The “child size medicines” concept: policy provisions in Uganda. J Pharm Policy Pract. 2015;8(1):2.
  • Nsabagasani X, Ogwal-Okeng J, Mbonye A, Ssengooba F, Muhumuza S, Hansen EH. Availability and utilization of the WHO recommended priority lifesaving medicines for under five-year old children in public health. J Pharm Policy Pract. 2015;8(1):18.
  • Stoltenberg I, Breitkreutz J. Orally disintegrating mini-tablets (ODMTs)-a novel solid oral dosage form for paediatric use. Eur J Pharmac Biopharm. 2011;78(3):462–9.
  • Adams LV, Craig SR, Mmbaga EJ, Naburi H, Lahey T, Nutt CT, et al. Children’s Medicines in Tanzania: A National Survey of Administration Practices and Preferences. PLoS One. 2013;8(3):e58303.
  • Muhumuza S, Olsen A, Katahoire A, Nuwaha F. Uptake of preventive treatment for intestinal schistosomiasis among school children in Jinja district, Uganda: a cross sectional study. PLoS One. 2013;8(5):e63438.
  • Keiser J, Ingram K, Utzinger J. Antiparasitic drugs for paediatrics: systematic review, formulations, pharmacokinetics, safety, efficacy and implications for control. Parasitology. 2011;138(12):1620–32.
  • Hoebert JM, van Dijk L, Mantel-Teeuwisse AK, Leufkens HG, Laing RO. National medicines policies - a review of the evolution and development processes. J Pharm Policy Pract. 2013;6:5.
  • Government of Uganda. Essential Medicines and Health Supplies List for Uganda 2012 (EMHSLU). Kampala: Ministry of Health;2012.
  • Government of Uganda. Uganda Clinical Guidelines. National Guidelines on Management of Common Conditions. Kampala: Ministry of Health, Uganda; 2010.
  • World Health Organization. Priority medicines for mothers and children. Geneva: WHO; 2011. http://cdrwww.who.int/medicines/publications/A3prioritymedicines.pdf. Accessed 19 March 2015.
  • World Health Organization. Priority life-saving medicines for women and children. WHO; 2012. http://www.who.int/reproductivehealth/publications/general/emp_mar2012.1/en/ Accessed 19 March 2015.
  • Dolowitz DP, Marsh D. Learning from abroad: The Role of Policy Transfer in the Contemporary Policy Making. Gov: Inter J Policy Adm. 2000;13(1):5–24.
  • Evans M. Policy transfer in critical perspective. Policy studies. 2009;30(3):243–68.
  • Walt G, Gilson L. Reforming the health sector in developing countries: the central role of policy analysis. Health Policy Plan. 1994;9(4):353–70.
  • Sabatier PA, Jenkins-Smith HC, editors. Policy Change and Learning: An Advocacy Coalition Approach. 1988.
  • Shore C, Wright S, editors. Policy: A new field of anthropology. New York: Routledge; 1997.
  • Republic of Uganda. National Population and Housing Census: Provisional Results. Kampala: Uganda Bureau of Statistics; 2014.
  • UNICEF. Uganda-Unicef Statistics In.: UNICEF; 2010.
  • Government of Uganda. Health Sector Strategic and Investment Plan: Promoting People’s Health to Enhance Socio-Economic Development. Kampala: Ministry of Health; 2010.
  • Patton MQ. Qualitative Research and Evaluation Methods. London: Sage Publications; 2002.
  • Graneheim U, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24:105–12.
  • Ministry of Health Uganda, SURE Program. Improving equity in resource allocation for essential medicnes and health supplies in public sector health facilities in Uganda. Kampala: Ministry of Health; 2014.
  • Nabyonga-Orem J, Ssengooba F, Macq J, Criel B. Malaria treatment policy change in Uganda: what role did evidence play? Malar J. 2014;13(1):345.
  • Mori AT, Kaale EA, Ngalesoni F, Norheim OF, Robberstad B. The Role of Evidence in the Decision-Making Process of Selecting Essential Medicines in Developing Countries: The Case of Tanzania. PLoS One. 2014;9(1):e84824.
  • Hansen DL, Tulinius D, Hansen EH. Adolescents’ struggles with swallowing tablets: barriers, strategies and learning. Pharm World Sci. 2008;30(1):65–9.
  • Gitanjali B. Essential medicines for children: Should we focus on a priority list of medicines for the present? J Pharmacol Pharmacotherapeutics. 2011;2(1):1–2.
  • Quinzler R, Gasse C, Schneider A, Kaufmann-Kolle P, Szecsenyi J, Haefeli WE. The frequency of inappropriate tablet splitting in primary care. Eur J Clin Pharmacol. 2006;62(12):1065–73.
  • Nunn T, Williams J. Formulation of medicines for children. Br J Clin Pharmacol. 2005;59(6):674–6.
  • Hill SR. Putting the priorities first: medicines for maternal and child health. Bull World Health Organ. 2012;90(3):236–8.
  • Orem JN, Mafigiri DK, Marchal B, Ssengooba F, Macq J, Criel B. Research, evidence and policymaking: the perspectives of policy actors on improving uptake of evidence in health policy development and implementation in Uganda. BMC Public Health. 2012;12:109.
  • Mori AT, Kaale EA, Risha P. Reforms: a quest for efficiency or an opportunity for vested interests’? A case study of pharmaceutical policy reforms in Tanzania. BMC Public Health. 2013;13:651.
  • Stone D. Transfer and translation of policy. Policy studies. 2012;33(6):483–99.
  • Walt G, Shiffman J, Schneider H, Murray SF, Brugha R, Gilson L. ‘Doing’ health policy analysis: methodological and conceptual reflections and challenges. Health Policy Plan. 2008;23(5):308–17.
  • Stephen H, editor. Policy Analysis. London and New York: Routledge; 2001.